T-Cells Can Predict Mesothelioma Treatment Success
Mesothelioma patients whose T-cell counts bounce back quickly after a round of chemotherapy have a better chance of survival. They are…
-
-
Mesothelioma Now Covered by Zadroga Act
First responders and others who have contracted malignant mesothelioma because of their exposure to asbestos during the 9/11 attacks in New York… -
Surgery | Treatments | Updates
Implants May Help Mesothelioma Surgery Patients
Mesothelioma patients who undergo surgery for their cancer may benefit from new biological implants to reconstruct their chest wall. Malignant pleural… -
Inhaling Mesothelioma Drug Soon Ready for Patient Trials
Mesothelioma patients may eventually be inhaling their treatment medications instead of receiving them intravenously if current research in Scotland goes according… -
New Tools Help Pathologists Make Mesothelioma Diagnosis
Pathologists may be able to do a better job of diagnosing mesothelioma in the lab, thanks to a new set of tools… -
Monoclonal Antibody a ‘Novel Treatment’ for Mesothelioma?
A drug currently used to treat colorectal cancer and some types of head and neck cancer may also offer a… -
Mesothelioma Risk High if Raised Near Asbestos
There’s more evidence that exposure to asbestos early in life increases the risk of mesothelioma and a host of other cancers. A… -
Mesothelioma Patients Lack Psychosocial Support
Most newly diagnosed mesothelioma patients need more psychosocial support than they are getting, according to a British sociologist. Sara Arber is a… -
New Chemo Research: Good and Bad News for Mesothelioma
Three new published studies contain a mixed bag of findings on the effectiveness of chemotherapy for mesothelioma. In a study designed… -
Cediranib Fails Phase II Mesothelioma Trial
Some disappointing news for mesothelioma patients and doctors who had high hopes for the chemotherapy drug cediranib. The oral cancer drug, made…
